Elizabeth Buck
Patrimonio netto: 314 855 $ in data 30/06/2026
Patrimonio netto: 314 855 $ in data 30/06/2026
Elizabeth Buck is the founder of Black Diamond Therapeutics, Inc. since 2014, holding the title of Chief Scientific Officer.
Former job at OSI Pharmaceuticals, Inc. from 2005 to 2013 as Assistant Director-Advanced Preclinical.
Former job at MetaStat, Inc. from 2013 to 2014 as Chief Scientific Officer-Therapeutics.
Education includes an undergraduate degree from the University of New Hampshire and a doctorate from Icahn School of Medicine at Mount Sinai.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/01/2026 | 170.192 ( 0,3% ) | 314 855 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Fondatore | 01/01/2014 |
| Società | Posizione | Fine |
|---|---|---|
| METASTAT, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2014 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MetaStat, Inc.
MetaStat, Inc. Electrical ProductsProducer Manufacturing Develops cancer diagnostics technologies | Producer Manufacturing |
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale